Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Webster Stephen W
Relationship:  
City:   Exton
State:   PA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   44,447    

Indirect Shares

   0      
Direct Value   $661,148    

Indirect Value

   $0      
Total Shares   44,447      
Total Value   $661,148      


Nabriva Therapeutics AG $4,508 Viking Therapeutics, Inc. $636,640 Gritstone Oncology, Inc. $20,000 Nabriva Therapeutics AG $4,508 Viking Therapeutics, Inc. $636,640 Gritstone Oncology, Inc. $20,000
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Adolor Corp ADLR SVP, Finance & CFO 2011-12-12 0 2009-12-15 0    Premium*  
            Optimer Pharmaceuticals Inc OPTR Chief Financial Officer 2013-10-24 0 2012-06-29 0    Premium*  
            Spark Therapeutics, Inc. ONCE CHIEF FINANCIAL OFFICER 2019-12-17 0 2015-02-04 0    Premium*  
            Nabriva Therapeutics AG NBRV Director 2022-08-02 11,447 2018-05-23 0    Premium*  
            Viking Therapeutics, Inc. VKTX Director 2018-05-29 8,000 2018-05-29 0    Premium*  
            Gritstone Oncology, Inc. GRTS 2024-04-26 25,000 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GRTS Gritstone Oncology, Inc.   –       •      –    2024-04-26 3 IO $0.00 $0 D/D 0 25,000 -
NBRV Nabriva Therapeutics AG Director   –       •      –    2022-08-02 4 S $0.19 $1,487 D/D (7,826) 11,447 0 -
NBRV Nabriva Therapeutics AG Director   –       •      –    2021-08-02 4 S $1.20 $932 D/D (777) 19,273 0 -
NBRV Nabriva Therapeutics AG Director   –       •      –    2021-07-28 4 A $0.00 $0 D/D 17,500 20,050 0 -
NBRV Nabriva Therapeutics AG Director   –       •      –    2020-07-29 4 A $0.00 $0 D/D 17,500 25,500 0 -
ONCE Spark Therapeutics, Inc. CHIEF FINANCIAL OFFICER   •       –      –    2019-12-17 4 D $114.50 $698,679 D/D (6,102) 0 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2019-01-18 4 D $45.08 $56,936 D/D (1,263) 6,102 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2019-01-18 4 OE $0.00 $0 D/D 3,750 6,731 0 -
VKTX Viking Therapeutics, Inc. Director   –       •      –    2018-05-29 4 B $5.21 $41,712 D/D 8,000 8,000 2.39 -
NBRV Nabriva Therapeutics AG Director   –       •      –    2018-05-23 4 B $4.59 $36,720 D/D 8,000 8,000 2.39 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2018-01-18 4 D $50.55 $32,099 D/D (635) 3,615 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2018-01-18 4 OE $0.00 $0 D/D 1,750 4,250 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-11-16 4 AS $70.14 $701,400 D/D (10,000) 2,500 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-11-16 4 OE $3.45 $34,500 D/D 10,000 12,500 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-08-15 4 AS $79.38 $793,800 D/D (10,000) 2,500 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-08-15 4 OE $3.45 $34,500 D/D 10,000 12,500 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-07-31 4 AS $71.12 $166,207 D/D (2,337) 2,500 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-07-31 4 OE $3.45 $8,063 D/D 2,337 4,837 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-06-19 4 AS $60.00 $459,780 D/D (7,663) 2,500 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-06-19 4 OE $3.45 $26,437 D/D 7,663 10,163 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-04-25 4 AS $55.22 $447,392 D/D (8,102) 2,500 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-04-25 4 OE $3.45 $27,952 D/D 8,102 10,602 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-04-24 4 AS $55.00 $104,390 D/D (1,898) 2,500 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2017-04-24 4 OE $3.45 $6,548 D/D 1,898 4,398 0 -
ONCE Spark Therapeutics, Inc. Chief Financial Officer   •       –      –    2016-05-20 4 S $50.38 $1,007,820 D/D (20,000) 2,500 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us